Data / Drug companies / Health Pharma USA LLC
Health Pharma USA LLC: 17 products in the FDA NDC directory, labeler code 71679
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Health Pharma USA LLC (labeler code 71679) lists 17 products in the FDA National Drug Code Directory, covering 10 finished drugs by generic name. By type: 17 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on June 27, 2026.
The request: Watch Health Pharma USA LLC (FDA labeler code 71679): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 71679
- Products in commercial distribution
- 17
- Packages
- 28
- Finished drugs by generic name
- 10
- Prescription products
- 0
- Over the counter products
- 17
- Flagged as original packager
- 17 of 17 products that carry the flag
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- January 1, 2022
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 16 | 94.1% |
| Generic drugs (ANDA) | 1 | 5.9% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 17 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Diphenhydramine hydrochloride | 3 | 127 |
| Aspirin | 2 | 134 |
| Guaifenesin | 2 | 123 |
| Acetaminophen | 2 | 214 |
| Diphenhydramine hcl 25 mg | 1 | 6 |
| Acetaminophen 250 mg aspirin 250 mg caffeine 65 mg | 1 | 1 |
| Aspirin 81 mg | 1 | 5 |
| Ibuprofen | 1 | 190 |
| Guaifenesin 400 mg | 1 | 8 |
| Acetaminophen, doxylamine succinate, dextromethorphan hbr | 1 | 5 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 7 | 41.2% |
| Tablet | 4 | 23.5% |
| Tablet, coated | 2 | 11.8% |
| Capsule, liquid filled | 2 | 11.8% |
| Tablet, delayed release | 2 | 11.8% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Diphenhydramine Hydrochloride | 71679-308 | Tablet, film coated | Over the counter monograph drugs | June 27, 2026 |
| Aspirin | 71679-302 | Tablet, film coated | Over the counter monograph drugs | April 24, 2026 |
| Pain Reliever | 71679-304 | Tablet, film coated | Over the counter monograph drugs | October 9, 2025 |
| Acetaminophen 325 mg, Dextromethorphan Hydrobromide 10 mg, Phenlyephrine Hydrochloride 5 mg softgel (DAY-TIME) | 71679-101 | Capsule, liquid filled | Over the counter monograph drugs | September 24, 2025 |
| Acetaminophen | 71679-305 | Tablet, film coated | Over the counter monograph drugs | September 23, 2025 |
| Allergy Relief | 71679-106 | Tablet | Over the counter monograph drugs | June 24, 2025 |
| Guaifenesin 200mg | 71679-148 | Tablet | Over the counter monograph drugs | June 18, 2025 |
| Mucus Relief | 71679-119 | Tablet | Over the counter monograph drugs | June 18, 2025 |
| Nighttime Sleep Aid | 71679-110 | Tablet, coated | Over the counter monograph drugs | June 18, 2025 |
| Pain reliever | 71679-104 | Tablet, delayed release | Over the counter monograph drugs | June 13, 2025 |
| Nighttime Cold and Flu | 71679-102 | Capsule, liquid filled | Over the counter monograph drugs | December 20, 2024 |
| Acetaminophen 500 Pyrilamine Maleate 15 and Caffeine 60 | 71679-312 | Tablet, film coated | Over the counter monograph drugs | March 7, 2024 |
| Diphenhydramine Hydrochloride | 71679-311 | Tablet, film coated | Over the counter monograph drugs | March 7, 2024 |
| Acetaminophen 250 mg Aspirin 250 mg Caffeine 65 mg | 71679-307 | Tablet, film coated | Over the counter monograph drugs | March 7, 2024 |
| Aspirin | 71679-301 | Tablet, delayed release | Over the counter monograph drugs | March 7, 2024 |
| Guaifenesin | 71679-309 | Tablet | Over the counter monograph drugs | February 7, 2024 |
| Pain Relief - Ibuprofen 200 mg | 71679-111 | Tablet, coated | Generic drugs (ANDA) | January 1, 2022 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.